Bruker Corp. Stock
Bruker Corp. Stock
Bruker Corp. gained 1.000% compared to yesterday.
We see a rather positive sentiment for Bruker Corp. with 16 Buy predictions and 1 Sell predictions.
With a target price of 45 € there is a positive potential of 41.15% for Bruker Corp. compared to the current price of 31.88 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 1.000% | 3.911% | -6.400% | -15.950% | -21.844% | - | - |
| Healthequity Inc. | 1.400% | -1.389% | 7.576% | -12.346% | -8.974% | 31.481% | 21.742% |
| Omnicell Inc. | 0.680% | -5.921% | -18.286% | -11.728% | -26.289% | -46.542% | -74.464% |
| Myriad Genetics | 3.550% | -0.510% | -8.451% | -51.852% | -26.415% | -81.750% | -85.404% |
Comments
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a